Deep Medicine Acquisition Corp. Files 8-K on Shareholder Vote Matters
Ticker: TRUG · Form: 8-K · Filed: Jan 25, 2024 · CIK: 1857086
| Field | Detail |
|---|---|
| Company | Deep Medicine Acquisition Corp. (TRUG) |
| Form Type | 8-K |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.0001, $4,355,556, $11.50 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, corporate-governance
TL;DR
**DMAQ filed an 8-K confirming its Nasdaq listing and shareholder vote matters.**
AI Summary
Deep Medicine Acquisition Corp. (DMAQ) filed an 8-K on January 25, 2024, reporting an event on January 19, 2024, related to the submission of matters to a vote of security holders. This filing indicates that DMAQ's Class A Common Stock, with a par value of $0.0001 per share, is registered on The Nasdaq Stock Market LLC under the trading symbol DMAQ. This matters to investors because it confirms the company's compliance with SEC reporting requirements and its continued listing on a major exchange, which is crucial for liquidity and investor confidence.
Why It Matters
This filing confirms Deep Medicine Acquisition Corp.'s ongoing compliance with SEC regulations and its active listing on Nasdaq, providing transparency for current and potential investors.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of administrative information and does not indicate any immediate financial or operational risks.
Analyst Insight
A smart investor would note this routine filing as confirmation of ongoing regulatory compliance, but it provides no new material information to drive investment decisions.
Key Numbers
- $0.0001 — Par Value per Share (Par value of Deep Medicine Acquisition Corp.'s Class A Common Stock)
Key Players & Entities
- Deep Medicine Acquisition Corp. (company) — the registrant filing the 8-K
- DMAQ (company) — trading symbol for Class A Common Stock
- $0.0001 (dollar_amount) — par value per share of Class A Common Stock
- The Nasdaq Stock Market LLC (company) — exchange where DMAQ Class A Common Stock is registered
- January 19, 2024 (date) — date of earliest event reported
- January 25, 2024 (date) — date the 8-K was filed
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is Deep Medicine Acquisition Corp.
What is the trading symbol for Deep Medicine Acquisition Corp.'s Class A Common Stock?
The trading symbol for Deep Medicine Acquisition Corp.'s Class A Common Stock is DMAQ.
On which exchange is Deep Medicine Acquisition Corp.'s Class A Common Stock registered?
Deep Medicine Acquisition Corp.'s Class A Common Stock is registered on The Nasdaq Stock Market LLC.
What was the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing was January 19, 2024.
What is the par value per share of Deep Medicine Acquisition Corp.'s Class A Common Stock?
The par value per share of Deep Medicine Acquisition Corp.'s Class A Common Stock is $0.0001.
Filing Stats: 1,854 words · 7 min read · ~6 pages · Grade level 16.6 · Accepted 2024-01-25 17:15:13
Key Financial Figures
- $0.0001 — tered Class A Common Stock, par value $0.0001 per share DMAQ The Nasdaq Stock Mar
- $4,355,556 — t (the " Trust Account "). As a result, $4,355,556 (approximately $11.50 per share) will b
- $11.50 — As a result, $4,355,556 (approximately $11.50 per share) will be removed from the Tru
Filing Documents
- form8-k.htm (8-K) — 87KB
- 0001493152-24-003782.txt ( ) — 308KB
- dmaq-20240119.xsd (EX-101.SCH) — 4KB
- dmaq-20240119_def.xml (EX-101.DEF) — 26KB
- dmaq-20240119_lab.xml (EX-101.LAB) — 36KB
- dmaq-20240119_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 5KB
07
Item 5.07 Submission of Matters to a Vote of Security Holders On January 19, 2024, Deep Medicine Acquisition Corp. (" DMAQ " or the " Company ") held a special meeting of its stockholders (the " Special Meeting "), at which holders of 3,952,979 shares of DMAQ's Class A common stock (the " Common Stock ") were present in person or by proxy, constituting a quorum for the transaction of business at the Special Meeting. Only stockholders of record as of the close of business on December 14, 2023, the record date for the Special Meeting, were entitled to vote at the Special Meeting. As of the record date, 4,357,964 shares of Common Stock were outstanding and entitled to vote at the Special Meeting. At the Special Meeting, the proposals listed below were presented, each of which is described in more detail in the Company's definitive proxy statement/prospectus filed with the Securities and Exchange Commission (the " SEC ") on December 29, 2023 (the " Proxy Statement/Prospectus "). A summary of the final voting results at the Special Meeting is set forth below: Proposal 1 – The NTA Proposal DMAQ's stockholders approved Proposal 1. The votes cast were as follows: For Against Abstain Broker Non-Votes 3,952,776 200 3 0 Proposal 2 – The Business Combination Proposal DMAQ's stockholders approved Proposal 2. The votes cast were as follows: For Against Abstain Broker Non-Votes 3,933,438 18,838 703 0 Proposal 3 – The Charter Proposal DMAQ's stockholders approved Proposal 3. The votes cast were as follows: For Against Abstain Broker Non-Votes 3,933,938 18,838 203 0 Proposals 4A-4E – The Governance Proposals DMAQ's stockholders approved Proposals 4A through 4E. The votes cast were as follows: Proposal 4A: For Against Abstain Broker Non-Votes 3,933,938 18,838 203 0 2 Proposal 4B: For Against Abstain Broker Non-Votes 3,933,941 18,838 200 0 Proposal 4C: For Against Abstain Broker Non-Votes 3,933,840